⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Aging Research Alliances and Institutional Funding
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-02 — FDA Leaders Name Longevity a Priority at ARDD: 2026 — FDA leadership presence at ARDD endorsing aging as a regulatory priority adds a federal-agency actor alongside private alliances and cohort infrastructure in the institutional mainstreaming of longevity research; conference remarks, no new funding or program commitments reported. [expert-opinion] (novelty: 4)
- 2026-09-08 — 100-Year Human Aging Study: 2026 — Announcement of the 100-Year Human Aging Study, a prospective lifespan-to-death cohort designed to validate multi-system biomarkers against all-cause/cause-specific mortality, incident serious disease, and functional disability; infrastructure announcement, no data yet. [expert-opinion] (novelty: 4)
Open questions
Related
Contributing findings
Japan Focus: Japan-Singapore MOU, healthy longevity, Asia’s growth potential and more
13-nov-2026
novelty 2
per-area 2
mentions
Business Schools Are Waking Up To Longevity. Now Comes The Hard Part.
09-nov-2026
novelty 2
per-area 2
mentions
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
06-oct-2026
novelty 2
per-area 2
introduces
FDA Leaders Name Longevity a Priority at ARDD
02-oct-2026
novelty 4
per-area 4
strengthens
Global Leaders in Geroscience Convene for Biomarkers of Aging
01-oct-2026
novelty 2
per-area 2
strengthens
Advancing aging biomarkers and intervention discovery at the TimePie Longevity Forum.
30-sep-2026
novelty 2
per-area 2
mentions
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
17-sep-2026
novelty 2
per-area 2
strengthens
From World Cup Champions to Longevity Champions
10-sep-2026
novelty 2
per-area 2
mentions
100-Year Human Aging Study
08-sep-2026
novelty 4
per-area 4
strengthens
Lone Korean biotech nears $81m antiaging prize
08-sep-2026
novelty 2
per-area 2
mentions
Transformative $37 million investment will create alliance to advance breakthroughs in aging research, clinical care
03-sep-2026
novelty 2
per-area 2
introduces
Baltimore Longitudinal Study of Aging
01-sep-2026
novelty 1
per-area 1
mentions
Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4
30-jul-2026
novelty 1
per-area 1
mentions